WEBINARS: Preclinical imaging in cancer research
12th April 2022
Find out about integrating PET, SPECT, and CT imaging in oncology in MOLECUBES' upcoming webinars
| Webinar Title | Date | Register |
| Preclinical imaging in oncology research with Dr. Geoff Warnock, Senior Application Scientist PMOD, and Dr. Sara Neyt, Product Manager | Tuesday April 19th 4PM BST | 5PM CET | Registration |
| PET imaging in preclinical mouse cancer models with Dr. Silvia Valtorta, PhD, IRCCS San Raffaele Scientific Institute | Tuesday April 26th 4PM BST | 5PM CET | Registration |
Webinar: Preclinical imaging in oncology research with Dr. Geoff Warnock, Senior Application Scientist PMOD, and Dr. Sara Neyt, Product Manager
Tuesday 19th April 9th 4PM BST | 5PM CET
In this webinar, MOLECUBES and PMOD will present the value and benefits of integrating PET, SPECT, and CT imaging in your oncology research. More specifically, this webinar will provide you with insights on how imaging can impact your research, highlight a few key applications, and demonstrate what info and data you can derive via imaging and data postprocessing.
Webinar: PET imaging in preclinical mouse cancer models with Dr. Silvia Valtorta, PhD, IRCCS San Raffaele Scientific Institute
Tuesday April 26th 4PM BST | 5PM CET
Cancer is a complex and heterogeneous disease, characterized by different hallmarks as identified by Hanahan and Weinberg in 2011. They can be summarized in the acquired capabilities for sustaining proliferative signalling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing/accessing vasculature, activating invasion and metastasis, reprogramming cellular metabolism, and avoiding immune destruction. In addition, the tumour microenvironment is composed of different cell populations, as immune cells, fibroblasts, precursor cells, endothelial cells, signalling molecules, and extracellular matrix (ECM) components play a role in tumorigenesis and in cancer progression.
The use of PET and selected radiopharmaceuticals has allowed imaging in vivo different biological features of tissue, such as glucose metabolism, cell proliferation, tissue hypoxia, inflammation, and matrix metalloproteinases that are associated with the tumour or tumour microenvironment. Imaging of tumour metabolism could lead to improved knowledge of the basic biologic mechanisms in oncology and generate novel approaches and treatments.
In this webinar, recent works related to the application of PET imaging in preclinical models of cancer carried out by the speaker’s research group will be discussed.